Proprietary formulations of WNT stem cell activators fur surgical application
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT04378543
Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2020
Completion: Oct 31, 2023
Loading map...